0001104659-20-029267.txt : 20200304
0001104659-20-029267.hdr.sgml : 20200304
20200304172248
ACCESSION NUMBER: 0001104659-20-029267
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200302
FILED AS OF DATE: 20200304
DATE AS OF CHANGE: 20200304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McLaughlin Gerald W.
CENTRAL INDEX KEY: 0001495412
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37508
FILM NUMBER: 20688396
MAIL ADDRESS:
STREET 1: 227 WASHINGTON STREET
STREET 2: SUITE 200
CITY: CONSHOHOCKEN
STATE: PA
ZIP: 19428
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Neos Therapeutics, Inc.
CENTRAL INDEX KEY: 0001467652
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 270395455
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2940 N. HIGHWAY 360
STREET 2: SUITE 400
CITY: GRAND PRAIRIE
STATE: TX
ZIP: 75050
BUSINESS PHONE: 972.408.1360
MAIL ADDRESS:
STREET 1: 2940 N. HIGHWAY 360
STREET 2: SUITE 400
CITY: GRAND PRAIRIE
STATE: TX
ZIP: 75050
4
1
a4.xml
4
X0306
4
2020-03-02
0
0001467652
Neos Therapeutics, Inc.
NEOS
0001495412
McLaughlin Gerald W.
C/O NEOS THERAPEUTICS, INC.
2940 N. HWY 360
GRAND PRAIRIE
TX
75050
1
1
0
0
Chief Executive Officer
Common Stock
2020-03-02
4
A
0
290000
0
A
314500
D
Stock Option (Right to Buy)
1.49
2020-03-02
4
A
0
395000
0
A
2030-03-02
Common Stock
395000
395000
D
Represents shares of common stock underlying restricted stock unit grants awarded to the Reporting Person. The restricted stock units will vest in two equal, annual installments beginning on March 2, 2021.
This stock option will vest in four equal, annual installments beginning on March 2, 2021.
/s/ Gerald McLaughlin
2020-03-04